Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Roivant is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- SCHEDULE 13D/A2026-10-05SCHEDULE 13D/A
- 8-K2026-09-18Current report (material event)
- 8-K2026-09-08Current report (material event)
- 8-K2026-08-28Current report (material event)
- 8-K2026-08-27Current report (material event)
- SCHEDULE 13G/A2026-08-13SCHEDULE 13G/A
- 10-Q2026-08-06Quarterly report
- 8-K2026-08-06Current report (material event)
- ARS2026-07-29Annual report to holders
- DEFA14A2026-07-29DEFA14A
- DEF 14A2026-07-29Proxy statement
- S-82026-05-20Employee stock plan
- 10-K2026-05-20Annual report
- 8-K2026-05-20Current report (material event)
- SCHEDULE 13G/A2026-05-12SCHEDULE 13G/A
- SCHEDULE 13G/A2026-05-06SCHEDULE 13G/A
- 8-K2026-04-02Current report (material event)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 8-K/A2026-03-23Current report (amended)
- SCHEDULE 13G/A2026-03-06SCHEDULE 13G/A
- 8-K2026-03-03Current report (material event)
- 8-K2026-03-03Current report (material event)
- SCHEDULE 13G/A2026-02-17SCHEDULE 13G/A
- SCHEDULE 13G/A2026-02-13SCHEDULE 13G/A
- SCHEDULE 13G/A2026-02-11SCHEDULE 13G/A
- 10-Q2026-02-06Quarterly report
- 8-K2026-02-06Current report (material event)
- SCHEDULE 13G/A2026-02-05SCHEDULE 13G/A
- SCHEDULE 13D/A2025-12-12SCHEDULE 13D/A
- 8-K2025-12-11Current report (material event)
- SCHEDULE 13G/A2025-11-14SCHEDULE 13G/A
- SCHEDULE 13G/A2025-11-14SCHEDULE 13G/A
- 10-Q2025-11-10Quarterly report
- 8-K2025-11-10Current report (material event)
- S-3ASR2025-10-03S-3ASR
- 8-K2025-09-17Current report (material event)
- 8-K2025-09-11Current report (material event)
- 8-K2025-09-03Current report (material event)
- SCHEDULE 13G/A2025-08-14SCHEDULE 13G/A
- SCHEDULE 13G/A2025-08-14SCHEDULE 13G/A
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.